- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07340060
Statistical Association Between Bicarbonate Levels and Death or Admission to Intensive Care Within 48 Hours in Patients Presenting to the Emergency Department (BRAVOinED)
August 27, 2026 updated by: Centre Hospitalier Departemental Vendee
Statistical Association Between Bicarbonate Levels and Death or Admission to Intensive Care Within 48 Hours in Patients Presenting to the Emergency Department
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
376
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
La Roche-sur-Yon, France
- Centre Hospitalier Departemental Vendee
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
This research is intended for adult patients admitted to the emergency department at CHD Vendée for whom an ionogram has been prescribed.
Description
Inclusion Criteria:
- Adult patient
- Patient with blood ionogram performed upon admission to the emergency department
- Patient capable of understanding the protocol and not opposed to participating in the research
Exclusion Criteria:
- NA
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Bicarbonate testing in patients admitted to the emergency department.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Composite criterion: -Admission to a critical care unit within 48 hours of admission to the emergency department. -Death within 48 hours of admission to the emergency department.
Time Frame: 48 hours
|
Composite criterion:
|
48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: COLIN Gwenhael, CHD Vendée
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 10, 2026
Primary Completion (Actual)
February 12, 2026
Study Completion (Actual)
August 10, 2026
Study Registration Dates
First Submitted
January 5, 2026
First Submitted That Met QC Criteria
January 5, 2026
First Posted (Actual)
January 14, 2026
Study Record Updates
Last Update Posted (Actual)
August 31, 2026
Last Update Submitted That Met QC Criteria
August 27, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- CHD25_0056
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.